Needham & Company LLC Forecasts Strong Price Appreciation for Plexus (NASDAQ:PLXS) Stock

Plexus (NASDAQ:PLXS) had its price target increased by Needham & Company LLC from $165.00 to $206.00 in a research report issued to clients and investors on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the technology company’s stock. Needham & Company LLC’s price objective indicates a potential upside of 3.35% from the stock’s current price.

Several other analysts have also recently commented on PLXS. Sidoti cut shares of Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price target for the company. in a report on Friday, October 24th. Williams Trading set a $195.00 target price on shares of Plexus in a research report on Wednesday. Benchmark boosted their price target on shares of Plexus from $165.00 to $195.00 and gave the company a “buy” rating in a report on Wednesday. Stifel Nicolaus set a $150.00 price target on shares of Plexus in a research note on Friday, October 24th. Finally, Wall Street Zen cut Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $189.20.

Plexus Price Performance

Shares of NASDAQ:PLXS opened at $199.33 on Friday. The stock has a market cap of $5.33 billion, a price-to-earnings ratio of 31.00 and a beta of 0.81. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.77. Plexus has a 12 month low of $103.43 and a 12 month high of $208.36. The stock’s 50 day moving average price is $159.97 and its 200 day moving average price is $145.94.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a net margin of 4.28% and a return on equity of 12.39%. Plexus’s revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the company earned $1.73 EPS. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. Equities research analysts anticipate that Plexus will post 5.9 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, Director Karen Marie Rapp sold 500 shares of Plexus stock in a transaction dated Friday, November 28th. The shares were sold at an average price of $143.47, for a total transaction of $71,735.00. Following the sale, the director directly owned 7,665 shares in the company, valued at approximately $1,099,697.55. The trade was a 6.12% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Patrick John Jermain sold 2,000 shares of Plexus stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $143.53, for a total value of $287,060.00. Following the sale, the chief financial officer directly owned 16,961 shares in the company, valued at $2,434,412.33. The trade was a 10.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 9,674 shares of company stock worth $1,382,876. 1.78% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Plexus

Several institutional investors have recently added to or reduced their stakes in the company. Delta Investment Management LLC bought a new position in shares of Plexus in the fourth quarter valued at about $216,000. Pictet Asset Management Holding SA grew its holdings in Plexus by 5.3% during the 4th quarter. Pictet Asset Management Holding SA now owns 4,568 shares of the technology company’s stock worth $671,000 after acquiring an additional 231 shares during the last quarter. Teacher Retirement System of Texas increased its position in Plexus by 5.6% in the 4th quarter. Teacher Retirement System of Texas now owns 48,701 shares of the technology company’s stock valued at $7,159,000 after acquiring an additional 2,574 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH raised its stake in shares of Plexus by 66.4% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,832 shares of the technology company’s stock worth $1,743,000 after acquiring an additional 4,720 shares during the last quarter. Finally, Evergreen Capital Management LLC raised its stake in shares of Plexus by 16.6% in the fourth quarter. Evergreen Capital Management LLC now owns 2,974 shares of the technology company’s stock worth $437,000 after acquiring an additional 423 shares during the last quarter. 94.45% of the stock is owned by institutional investors.

Plexus News Summary

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Plexus raised Q2 FY2026 EPS guidance to $1.80–$1.95 versus the Street at ~$1.63, and issued higher revenue guidance — a direct fundamental catalyst supporting a higher valuation and nearby analyst upgrades.
• Positive Sentiment: Needham upgraded/raised its price target to $206 and reiterated a Buy rating, highlighting the stronger start to fiscal 2026 and supporting upside momentum. Needham raises PT to $206 (Benzinga)
• Positive Sentiment: Benchmark raised its price target to $195, another vote of confidence from the sell-side that helps buoy the stock. Benchmark boosts PT to $195
• Positive Sentiment: Company commentary and analyst notes point to program ramps and market-share gains that could drive >12% revenue growth in FY2026 — a growth trajectory that justifies multiple expansion. Seeking Alpha: >12% revenue growth potential
• Positive Sentiment: Analyst write-ups and a Yahoo deep-dive attribute the guidance upgrade to specific program ramps and new manufacturing wins — concrete operational drivers versus one-off items. Yahoo: Q4 deep dive — program ramps
• Positive Sentiment: Plexus reported Q1 EPS of $1.78 (beat by $0.01) and revenue up ~9.6% year-over-year — topline growth and a modest EPS beat help validate the raised guidance. Zacks: Q1 earnings beat
• Neutral Sentiment: Some media/analyst coverage remains mixed on valuation and near-term sustainability of growth — expect debate on how much of the guidance is driven by a few large program ramps versus broad-based demand. Globe & Mail: mixed analyst opinions
• Neutral Sentiment: Full earnings materials and the call transcript are available for investors who want line-item detail and management’s tone on sustainability of margins and program timing. Earnings call transcript (Seeking Alpha)

Plexus Company Profile

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.